Theravance Biopharma, Inc. — SCHEDULE 13G/A Filings
3 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Theravance Biopharma, Inc. (TBPH), sorted by most recent first. Each row links to the full filing on EdgarLookup. Theravance Biopharma, Inc. has filed 3 SCHEDULE 13G/A documents with the SEC since 2015. To view all SEC filings by Theravance Biopharma, Inc., see the full filings list.
All
10-12B
10-12B/A
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
EFFECT
FWP
PRE 14A
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001493152-26-007116 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0002052113-25-002028 | Apr 30, 2025 | — |
| SCHEDULE 13G/A | — | 0001493152-25-006843 | Feb 14, 2025 | — |